Role of PPARγ in the salutary effects of 17β‐estradiol on kupffer cell cytokine production following trauma‐hemorrhage
- 26 October 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 226 (1) , 205-211
Abstract
Studies have shown that administration of 17β‐estradiol prevents trauma‐hemorrhage‐induced increase in proinflammatory cytokine production by Kupffer cells and associated multiple organ injury. Since activation of peroxisome proliferator‐activated receptor γ (PPARγ) following ischemic conditions has been shown to be protective, we examined if PPARγ plays any role in the salutary effects of 17β‐estradiol on Kupffer cell cytokine production following trauma‐hemorrhage. Male mice underwent trauma‐hemorrhage (mean blood pressure 40 mmHg for 90 min, then resuscitation). 17β‐estradiol (50 µg/kg) or vehicle with or without PPARγ antagonist GW9662 was injected subcutaneously at the middle of resuscitation. At 2 h after trauma‐hemorrhage, plasma interleukin (IL)‐6 and tumor necrosis factor (TNF)‐α levels, Kupffer cell IL‐6 and TNF‐α production and mRNA expression, and PPARγ, nuclear factor (NF)‐κB and activator protein (AP)‐1 DNA binding activity were determined. Kupffer cell IL‐6 and TNF‐α production, as well as plasma IL‐6 and TNF‐α levels, increased following trauma‐hemorrhage. Moreover, NF‐κB and AP‐1 DNA binding activity and IL‐6 and TNF‐α mRNA expression were also enhanced under such conditions. However, 17β‐estradiol administration normalized all these parameters. Although PPARγ activity decreased after trauma‐hemorrhage, administration of 17β‐estradiol following trauma‐hemorrhage elevated PPARγ activity above the normal level. Inhibition of PPARγ by co‐administration of GW9662, however, abolished the salutary effects of 17β‐estradiol on plasma cytokine and Kupffer cells. Thus, activation of PPARγ appears to play an important role in mediating the salutary effects of 17β‐estradiol on plasma cytokine levels and Kupffer cell cytokine production after trauma‐hemorrhage, which are likely mediated via NF‐κB and AP‐1. J. Cell. Physiol. 226: 205–211, 2010.Keywords
This publication has 51 references indexed in Scilit:
- IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarctionProceedings of the National Academy of Sciences, 2009
- Murine dendritic cell antigen-presenting cell function is not altered by burn injuryJournal of Leukocyte Biology, 2009
- Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γBlood, 2008
- Coordination of inflammation and metabolism by PPAR and LXR nuclear receptorsCurrent Opinion in Genetics & Development, 2008
- A Role of PPAR-?? in Androstenediol-Mediated Salutary Effects on Cardiac Function Following Trauma-HemorrhageAnnals of Surgery, 2006
- 15-DEOXY-??12,14-PROSTAGLANDIN J2 (15D-PGJ2), A PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ?? LIGAND, REDUCES TISSUE LEUKOSEQUESTRATION AND MORTALITY IN ENDOTOXIC SHOCKShock, 2005
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-?? IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATIONShock, 2005
- Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shockJournal of Applied Physiology, 2004
- Molecular Mechanisms of the Effect of Herpesvirus saimiri Protein StpC on the Signaling Pathway Leading to NF-κB ActivationJournal of Biological Chemistry, 2004
- Role of peroxisome proliferator-activated receptor-γ in the protection afforded by 15-deoxyΔ12,14 prostaglandin J2 against the multiple organ failure caused by endotoxinCritical Care Medicine, 2004